NCT06160895 - A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 26, 2023

Primary Completion Date

June 24, 2024

Study Completion Date

August 19, 2024

Conditions

Hepatitis B

Interventions

DRUG

TQ-A3334 tablets

TQ-A3334 tablet is a Toll like receptor 7 (TLR7) agonist.

DRUG

TQ-A3334 placebo tablets

TQ-A3334 placebo tablet is a placebo that has no effect on TLR7.

Trial Locations (1)

The first hospital of Jilin University, Changchun